Loading
Latest filing published 27 Sept 2021 for Dr. Reddy's Laboratories Limited, €21k. Read the official filing
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of B. Mallikharjuna Rao in Dr. Reddy's Laboratories Limited, where the filings describe the role as chief executive. In total, 8 filings cover trades dated from 19 May 2021 to 23 September 2021.
Sales make up the whole of the open-market record (2 sales, €33k). Besides market trades, the filings include 6 share grants.
For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -10.5%. This is a record of the past, not a forecast.
The latest filing, published on 27 September 2021, reports a share grant of €21k in Dr. Reddy's Laboratories Limited. Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations